GHK-Cu

Skin + Glow

The science behind the glow.

A copper-binding tripeptide that connects skin research with the biology of the extracellular matrix—the framework surrounding our cells.

  • Skin biology
  • Collagen signaling
  • Extracellular matrix
  • Tissue remodeling

Evidence reviewed October 2, 2026 · Educational overview

01 / THE COMPOUND

What is it?

GHK is a short chain of three amino acids originally isolated from human plasma. When bound to copper, it is called GHK-Cu. Researchers study this complex in models of connective tissue and repair. [1–3]

02 / THE OPPORTUNITY TO LEARN

Why researchers are interested

Collagen, in context

Cultured fibroblasts exposed to GHK-Cu produced more collagen in a foundational laboratory study. That makes collagen regulation an interesting research question—not a demonstrated cosmetic result for this inventory. [1]

The matrix around the cell

Separate cell experiments examined glycosaminoglycans, molecules that form part of the extracellular matrix. The response varied with experimental conditions. [2]

Repair biology

Rat wound experiments reported changes in connective-tissue accumulation. Animal wound models cannot establish healing or recovery benefits in people. [3]

03 / RESEARCH INTEREST

Follow the questions.

  • Skin biology
  • Collagen signaling
  • Extracellular matrix
  • Tissue remodeling

04 / THE BIOLOGY

How it works

  1. Copper-binding peptide
  2. Fibroblast / matrix activity
  3. Connective-tissue research

The selected experiments link GHK-Cu exposure to collagen and other matrix components. This is a model of research observations, not a complete receptor pathway or a prediction of what a finished product will do. [1–3]

05 / PUBLISHED FINDINGS

What research has observed

Laboratory

Maquart and colleagues (1988) observed increased collagen synthesis in cultured fibroblasts. A later study examined glycosaminoglycan synthesis in human fibroblast cultures. Human cells in a dish are laboratory evidence, not a human clinical trial. [1,2]

Animal / preclinical

A 1993 rat study found increased connective-tissue components in experimental wound chambers. Its model and experimental exposure differ from everyday skin use. [3]

06 / EVIDENCE SNAPSHOT

Different evidence. Different conclusions.

These descriptive labels summarize the selected evidence. They are not numerical quality scores or product ratings.

Laboratory / animal
Mechanistic and wound-model findings
Human research
Selected evidence does not establish clinical outcomes
Therapeutic use
No therapeutic approval claimed for this inventory

07 / OPEN QUESTIONS

What we still don’t know

Which formulations reproduce these findings in people, their meaningful clinical effects, and long-term safety remain unresolved by the studies selected here. No hair-growth, wound-healing, or skin-rejuvenation result is promised.

08 / GO TO THE SOURCE

Selected research

  1. Maquart et al. (1988) — collagen synthesis in fibroblast cultures ↗
  2. Glycosaminoglycan synthesis in fibroblast cultures (1992) ↗
  3. Maquart et al. (1993) — rat experimental wounds ↗

09 / TRACEABILITY

Testing & documentation

Published studies are not a Certificate of Analysis for our inventory.

No verified lot-specific reports have been supplied for this compound. Identity, assay, purity, laboratory, testing date, sterility, endotoxin, and expiration must be supported by the applicable record before a claim is shown.

10 / RESEARCH FORMATS

From the inventory

Two inventory entries: 50 and 100. Units and finished-product formulation await label confirmation; neither is presented as an available strength.

Inventory references: GHKCU-50 · GHKCU-100

View product: GHKCU-50 →

View product: GHKCU-100 →

Membership does not change the evidence or imply that ordering is available. Research information is not medical advice or a protocol for human use.